|
Volumn 40, Issue 1, 1999, Pages 1-8
|
Clinical outcomes in low grade follicular lymphoma
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FOLINIC ACID;
MACOP B PROTOCOL;
MACOP-B PROTOCOL;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
FEMALE;
HUMAN;
LYMPHOCYTOMA;
MALE;
MIDDLE AGED;
MIXED CELL LYMPHOMA;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NONHODGKIN LYMPHOMA;
PATHOLOGY;
RADIATION DOSE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
LEUCOVORIN;
LYMPHOMA, LOW-GRADE;
LYMPHOMA, MIXED-CELL, FOLLICULAR;
LYMPHOMA, SMALL CLEAVED-CELL, FOLLICULAR;
MALE;
METHOTREXATE;
MIDDLE AGED;
PREDNISONE;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0032602546
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|